FDA Calendar for Vernalis plc (ADR) (VNLPY.PK)

| Register (free)
Vernalis plc is a development stage pharmaceutical company engaged in the research, development and commercialization of pharmaceutical products for a range of medical disorders. It focuses both in de novo fragment and structure-based drug discovery, and pre-clinical and clinical development. The Company has seven product candidates in clinical development (two of which are partnered), two programmes in pre-clinical (one with a partner) and other research programmes. It has one marketed product and a pipeline of clinical drug candidates and research programmes. Its product pipeline includes V3381, V1512, V10153, V2006 (BIIB014), V85546, V24343, NVP-AUY922, Hsp90 inhib. (Oral), FAAH V158866 and Checkpoint Kinase 1 (Chk1). On July 1, 2008, the Company announced that it had completed the sale of Apokyn and Vernalis Pharmaceuticals Inc, its United States commercial operations, to Ipsen SA.

Around The Net


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
This company currently does not have any drugs. If you would like to create one please click here.


Events

No future events listed at this time, please check back later.

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

VNLPY.PK

$0.77
0.00 0.00%
1/20/2012 10:40:00 AM

Sponsors

Other Links